Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-15
DOI
10.1186/s12933-022-01516-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
- (2022) Joshua J. Joseph et al. CIRCULATION
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
- (2022) Peter Rossing et al. DIABETES CARE
- Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease
- (2022) Isabel Fegers-Wustrow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
- (2021) Mon Myat Oo et al. BMJ Open
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- All-cause mortality and cardiovascular safety of basal insulin treatment in patients with type 2 diabetes mellitus: A systematic review with meta-analysis and trial sequential analysis
- (2021) Dimitris Varvaki Rados et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and Safety of Long‐Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta‐analysis of Randomized Controlled Trials
- (2021) Houyong Zhu et al. Journal of the American Heart Association
- Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records
- (2021) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
- (2021) Maurizio Averna et al. ATHEROSCLEROSIS
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
- (2021) Hang-Long Li et al. Cardiovascular Diabetology
- Novel therapies with precision mechanisms for type 2 diabetes mellitus
- (2021) Leigh Perreault et al. Nature Reviews Endocrinology
- Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study
- (2021) Arnaud D. Kaze et al. Journal of the American Heart Association
- Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
- (2021) Esther Artime et al. Diabetes Therapy
- CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
- (2021) Ofri Mosenzon et al. Cardiovascular Diabetology
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
- (2021) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- The aetiology and molecular landscape of insulin resistance
- (2021) David E. James et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in type 2 diabetes mellitus disease burden in European Union countries between 1990 and 2019
- (2021) Richard Goodall et al. Scientific Reports
- Duration of Diabetes and Incident Heart Failure
- (2021) Justin B. Echouffo-Tcheugui et al. JACC-Heart Failure
- SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
- (2021) Dario Giugliano et al. Cardiovascular Diabetology
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
- (2021) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
- (2021) Milad Nazarzadeh et al. LANCET
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- (2021) Stefano Del Prato et al. LANCET
- Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
- (2021) Jae-Seung Yun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Effects of the dual sodium‐glucose linked transporter inhibitor, licogliflozin versus placebo or empagliflozin in patients with type 2 diabetes and heart failure
- (2020) Rudolf A. Boer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study
- (2020) Lin Zhu et al. Cardiovascular Diabetology
- Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2020) Paul Guedeney et al. Journal of Clinical Medicine
- Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
- (2020) Suzanne V. Arnold et al. CIRCULATION
- Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials
- (2020) Eliano P. Navarese et al. CIRCULATION
- Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
- (2020) Mauro Chiarito et al. LANCET
- Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
- (2020) Dianna J. Magliano et al. Nature Reviews Endocrinology
- Metformin use in prediabetes: is earlier intervention better?
- (2020) Andrew Warrilow et al. ACTA DIABETOLOGICA
- The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis
- (2020) Yang Hua et al. American Journal of Cardiovascular Drugs
- Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
- (2020) Naoto Katakami et al. Cardiovascular Diabetology
- Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
- (2020) Safi U. Khan et al. CIRCULATION
- The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention
- (2020) Michelle L. O’Donoghue et al. CIRCULATION
- Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
- (2020) Xiaoyan Cai et al. BMJ-British Medical Journal
- SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
- (2020) Wen-jie Li et al. Cardiovascular Diabetology
- Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial
- (2020) Francesco Cosentino et al. CIRCULATION
- Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome
- (2020) Alan P. Jacobsen et al. CIRCULATION
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discontinuing Aspirin After Short Term Use Versus Continuous Use with a P2Y12 Inhibitor for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Meta-analysis
- (2020) Qiang Wang et al. Diabetes Therapy
- Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
- (2020) William T Abraham et al. EUROPEAN HEART JOURNAL
- Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years
- (2020) Julian W Sacre et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis
- (2020) Karan R. Chadda et al. Obesity Reviews
- Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea
- (2020) Jung Hwan Park et al. Diabetes & Metabolism Journal
- Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
- (2019) Stephanie A Amiel et al. Lancet Diabetes & Endocrinology
- Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events
- (2019) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study
- (2019) Natasha C. Bergmann et al. DIABETOLOGIA
- Standards of medical care for type 2 diabetes in China‐0027
- (2019) Weiping Jia et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program
- (2019) Gemma A. Figtree et al. CIRCULATION
- Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies
- (2019) Xiaofeng Ye et al. Cardiovascular Diabetology
- A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
- (2019) Mohapradeep Mohan et al. EUROPEAN HEART JOURNAL
- Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
- (2019) Shannon M. Dunlay et al. CIRCULATION
- Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
- (2019) Shang-He-Lin Yin et al. BMJ-British Medical Journal
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Peter J Grant et al. EUROPEAN HEART JOURNAL
- Marine Omega‐3 Supplementation and Cardiovascular Disease: An Updated Meta‐Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants
- (2019) Yang Hu et al. Journal of the American Heart Association
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes
- (2019) Anders Hostrup Larsen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption
- (2019) David R Powell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017
- (2018) Thomas R. Einarson et al. Cardiovascular Diabetology
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data
- (2018) Edward W Gregg et al. LANCET
- A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
- (2018) Safi U Khan et al. European Journal of Preventive Cardiology
- Global trends in diabetes complications: a review of current evidence
- (2018) Jessica L. Harding et al. DIABETOLOGIA
- Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
- (2018) Lorenzo M. Vetrone et al. ACTA DIABETOLOGICA
- Platelet activity and hypercoagulation in type 2 diabetes
- (2018) Lesha Pretorius et al. Cardiovascular Diabetology
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials
- (2018) Ahmed N Mahmoud et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials
- (2017) Konstantinos C Koskinas et al. EUROPEAN HEART JOURNAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
- (2016) Jessica A. Martinez et al. BMC CANCER
- Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseClinical Perspective
- (2016) Francesco Franchi et al. CIRCULATION
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusClinical Perspective
- (2016) Yoshihiko Saito et al. CIRCULATION
- Analyses of Results From Cardiovascular Safety Trials With DPP-4 Inhibitors: Cardiovascular Outcomes, Predefined Safety Outcomes, and Pooled Analysis and Meta-analysis
- (2016) Edoardo Mannucci et al. DIABETES CARE
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diverse roles of miR-335 in development and progression of cancers
- (2016) Long-ji Luo et al. TUMOR BIOLOGY
- Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
- (2016) Yuli Huang et al. BMJ-British Medical Journal
- Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
- (2016) Yuli Huang et al. BMJ-British Medical Journal
- Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
- (2015) M. A. Bethel et al. DIABETIC MEDICINE
- Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial
- (2015) Pardeep S. Jhund et al. EUROPEAN HEART JOURNAL
- Mean HbA1cand mortality in diabetic individuals with heart failure: a population cohort study
- (2015) Douglas H.J. Elder et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
- (2014) Julio Rosenstock et al. DIABETES CARE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome
- (2012) Katie Ayers et al. HYPERTENSION
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Thrombus and antiplatelet therapy in type 2 diabetes mellitus
- (2012) G. N. Viswanathan et al. THROMBOSIS AND HAEMOSTASIS
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)
- (2009) Arijit Dasgupta et al. AMERICAN JOURNAL OF CARDIOLOGY
- Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men
- (2009) Yasuaki Hayashino et al. AMERICAN JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search